ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

23.27
Delayed Data
As of Sep 25
 -0.27 / -1.15%
Today’s Change
13.73
Today|||52-Week Range
33.99
+46.17%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$3.9B

Company Description

ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

Contact Information

ACADIA Pharmaceuticals, Inc.
12830 El Camino Real
San Diego California 92130-3331
P:(858) 558-2871
Investor Relations:

Employees

Shareholders

Other institutional65.86%
Individual stakeholders32.63%
Mutual fund holders31.95%

Top Executives

Stephen R. DavisChief Executive Officer & Director
Brendan P. TeehanChief Operating Officer, EVP & Head-Commercial
Mark C. SchneyerChief Financial Officer & Executive Vice President
Ponni SubbiahChief Medical Officer & Senior Vice President
Sanjeev PathakSenior Vice President & Head-Clinical Development